台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    101.0
  • 漲跌
    ▲0.5
  • 漲幅
    +0.50%
  • 成交量
    25
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-華南永昌-斗六 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-斗六 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/143101.8300.00102.0031442.07%
2024/05/0700.001119.50119.50-1119-0.84%
2024/04/162114.5000.00114.0021111.80%
2024/04/091.3124.1200.00124.001.3771.68%
2024/03/251123.5000.00124.001621.60%
2024/03/0500.000.1113.00113.50-0.133-0.30%
2023/09/150.1115.0000.00114.000.1260.38%
2023/07/250.1111.0000.00110.500.1310.16%
2023/07/050.3108.5000.00107.500.3450.66%
2023/04/1300.000118.50119.50047-0.04%
2022/12/3000.001108.00108.00-139-2.52%
2022/12/0800.001105.00105.00-138-2.60%
2022/11/301100.0000.00100.001273.57%
2022/11/231100.0000.00100.001244.12%
2022/07/181107.001107.00107.000420.00%
2022/07/1500.001100.50102.00-141-2.40%
2022/07/131105.5000.00103.001422.37%
2022/06/23098.0000.0097.700460.04%
2022/04/1400.001125.50126.00-125-3.95%
2022/04/131134.000134.50134.001244.00%
2022/03/311135.0000.00135.001214.75%
2022/02/100126.500.2127.00127.00-0.121-0.61%
2022/01/174125.8800.00126.0042317.11%
2021/11/150.2127.0000.00125.500.2300.49%
2021/09/1500.000144.00143.50034-0.06%
2021/09/1000.000143.00143.50034-0.08%
2021/08/101153.001152.50152.500350.00%
2021/08/0600.001149.00149.50-134-2.91%
2021/08/051147.5000.00147.501342.90%
2021/08/0400.001144.50144.00-136-2.72%
2021/08/031155.0000.00156.001352.80%
2021/04/2200.002146.25146.50-237-5.27%
2021/04/2100.001146.50146.50-137-2.65%
2021/04/1300.000.2148.00149.00-0.237-0.40%
2021/04/060.2138.5000.00138.000.2310.47%
2021/04/0100.002141.50139.50-230-6.49%
2021/03/2300.005141.00141.00-527-18.44%
2021/03/0400.000.2129.00129.00-0.226-0.56%
2021/02/2600.000.2127.00127.00-0.226-0.56%
2021/02/1700.000.3124.50123.50-0.329-0.98%
2021/01/080.1123.0000.00123.000.1340.15%
2020/12/280.4123.5000.00122.500.4341.27%
2020/12/2400.000.1122.00123.00-0.135-0.28%
2020/12/150.1122.5000.00121.000.1350.25%
2020/11/2300.005121.00120.50-534-14.40%
2020/06/300.1107.5000.00107.500.1620.16%
2020/06/195114.5000.00114.505559.00%
2020/06/1810114.5000.00115.00105418.43%
2020/02/170101.0000.00101.000260.00%
2019/12/3000.001102.00102.00-120-4.87%
2019/12/0400.001101.50101.50-120-4.96%
2019/11/261102.0000.00102.001204.78%
2019/11/181102.0000.00101.501214.61%
2019/08/071102.0000.00102.001432.32%
2019/04/0900.000.1109.00109.00-0.135-0.28%
2019/03/140.1109.0000.00110.000.1250.31%
2018/07/130124.0000.00124.500820.02%
2018/05/071133.501131.00131.5001240.00%
2018/03/021120.501119.00120.0001750.00%
2018/01/1800.001122.50121.50-1134-0.74%
2018/01/051112.0000.00112.001991.00%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音